Loading...

NMRA NEUMORA THERAPEUTICS INC Earnings Reports 8-K Filing

NMR

NMR

NEUMORA THERAPEUTICS INC

(NMRA)

2026 8-K

Financial Results Announcement

Investor Presentation

Investor Presentation

Positive Study Results

Stock Conversion Notice

Financial Results Update

Phase 1 Study Initiated

Positive Drug Data

Financial Statements

Delisting due to Non-Compli...

Financial Statements

Financial Results

Leadership Changes

Leadership Changes

Investor Presentation

Q3 Financial Results

External Links:

Neumora Therapeutics, Inc. reported its financial results for Q4 and the full year ended December 31, 2025, on March 30, 2026. The filing includes a press release with detailed insights into the company's performance during that period.

AI Assistant

NEUMORA THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.